Orbimed Advisors LLC Xtant Medical Holdings, Inc. Transaction History
Orbimed Advisors LLC
- $4.44 Billion
- Q1 2024
A detailed history of Orbimed Advisors LLC transactions in Xtant Medical Holdings, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 73,114,592 shares of XTNT stock, worth $46.1 Million. This represents 1.93% of its overall portfolio holdings.
Number of Shares
73,114,592
Previous 73,114,592
-0.0%
Holding current value
$46.1 Million
Previous $82.6 Million
3.54%
% of portfolio
1.93%
Previous 2.02%
Shares
6 transactions
Others Institutions Holding XTNT
# of Institutions
34Shares Held
90.4MCall Options Held
0Put Options Held
0-
Altium Capital Management LP New York, NY7.65MShares$4.82 Million5.04% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4MShares$2.52 Million0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.55MShares$975,4360.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny763KShares$480,8850.0% of portfolio
-
Amh Equity LTD500KShares$315,0000.6% of portfolio
About Xtant Medical Holdings, Inc.
- Ticker XTNT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 108,226,000
- Market Cap $68.2M
- Description
- Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healin...